Reviva Pharmaceuticals Holdings, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Reviva Pharmaceuticals Holdings, Inc. (RVPH) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$185.03 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-12
- Reviva Pharmaceuticals Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$148.78K.
- Reviva Pharmaceuticals Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$36.25K, a 140.44% decline year-over-year.
- Reviva Pharmaceuticals Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $416.76K, a 22.35% increase year-over-year.
- Reviva Pharmaceuticals Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$99.04K.
- Reviva Pharmaceuticals Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$1.75K, a 100.42% decline from fiscal 2024.
- Reviva Pharmaceuticals Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $411.80K, a 256.84% increase from fiscal 2023.
- Reviva Pharmaceuticals Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $115.40K.
- Reviva Pharmaceuticals Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$1.31M, a 176.55% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 2 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 5 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 8 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 11 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$148.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$185.03K 10-Q · filed 2026-08-12 | $231.73K derived: sum of 3 quarters · filed 2026-08-12 | $132.69K derived: sum of 4 quarters · filed 2026-08-12 | ||||||
| 2026-03-31 | -$36.25K 10-Q · filed 2026-05-13 | $380.51K derived: sum of 2 quarters · filed 2026-05-13 | $281.47K derived: sum of 3 quarters · filed 2026-05-13 | -$127.63K derived: sum of 4 quarters · filed 2026-08-12 | ||||||
| 2025-12-31 | $416.76K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $317.72K derived: sum of 2 quarters · filed 2026-03-30 | -$91.38K derived: sum of 3 quarters · filed 2026-08-12 | -$1.75K 10-K · filed 2026-03-30 | ||||||
| 2025-09-30 | -$99.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$508.14K derived: sum of 2 quarters · filed 2026-08-12 | -$418.51K 10-Q · filed 2025-11-13 | -$77.88K derived: sum of 4 quarters · filed 2026-08-12 | ||||||
| 2025-06-30 | -$409.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$319.47K 10-Q · filed 2026-08-12 | $21.16K derived: sum of 3 quarters · filed 2026-08-12 | -$178.86K derived: sum of 4 quarters · filed 2026-08-12 | ||||||
| 2025-03-31 | $89.63K 10-Q · filed 2026-05-13 | $430.26K derived: sum of 2 quarters · filed 2026-05-13 | $230.24K derived: sum of 3 quarters · filed 2026-05-13 | $12.69K derived: sum of 4 quarters · filed 2026-05-13 | ||||||
| 2024-12-31 | $340.63K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $140.61K derived: sum of 2 quarters · filed 2026-03-30 | -$76.95K derived: sum of 3 quarters · filed 2026-03-30 | $411.80K 10-K · filed 2026-03-30 | ||||||
| 2024-09-30 | -$200.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$417.57K derived: sum of 2 quarters · filed 2025-11-13 | $71.17K 10-Q · filed 2025-11-13 | $175.65K derived: sum of 4 quarters · filed 2025-11-13 | ||||||
| 2024-06-30 | -$217.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $271.19K 10-Q · filed 2025-08-14 | $375.67K derived: sum of 3 quarters · filed 2025-08-14 | $99.97K derived: sum of 4 quarters · filed 2025-08-14 | ||||||
| 2024-03-31 | $488.74K 10-Q · filed 2025-05-15 | $593.22K derived: sum of 2 quarters · filed 2025-05-15 | $317.52K derived: sum of 3 quarters · filed 2025-05-15 | -$611.97K derived: sum of 4 quarters · filed 2025-05-15 | ||||||
| 2023-12-31 | $104.48K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-03 | -$171.22K derived: sum of 2 quarters · filed 2025-04-03 | -$1.10M derived: sum of 3 quarters · filed 2025-04-03 | $115.40K 10-K · filed 2025-04-03 | -$70.89K 10-K · filed 2024-04-15 | |||||
| 2023-09-30 | -$275.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$1.21M derived: sum of 2 quarters · filed 2024-11-14 | $10.92K 10-Q · filed 2024-11-14 | -$226.73K derived: sum of 4 quarters · filed 2024-11-14 | ||||||
| 2023-06-30 | -$929.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $286.62K 10-Q · filed 2024-08-14 | $48.97K derived: sum of 3 quarters · filed 2024-08-14 | -$363.64K derived: sum of 4 quarters · filed 2024-08-14 | ||||||
| 2023-03-31 | $1.22M 10-Q · filed 2024-05-14 | $1.24M 10-Q · filed 2023-05-15 | $978.47K derived: sum of 2 quarters · filed 2024-05-14 | $565.85K derived: sum of 3 quarters · filed 2024-05-14 | $14.09K derived: sum of 4 quarters · filed 2024-05-14 | |||||
| 2022-12-31 | -$237.65K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15 | -$650.27K derived: sum of 2 quarters · filed 2024-04-15 | -$1.20M derived: sum of 3 quarters · filed 2024-04-15 | -$1.31M 10-K · filed 2024-04-15 | ||||||
| 2022-09-30 | -$412.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$964.37K derived: sum of 2 quarters · filed 2023-11-14 | -$1.07M 10-Q · filed 2023-11-14 | $337.53K derived: sum of 4 quarters · filed 2023-11-14 | ||||||
| 2022-06-30 | -$551.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$661.97K 10-Q · filed 2023-08-14 | $750.15K derived: sum of 3 quarters · filed 2023-08-14 | $418.53K derived: sum of 4 quarters · filed 2023-08-14 | ||||||
| 2022-03-31 | -$110.21K 10-Q · filed 2023-05-15 | $1.30M derived: sum of 2 quarters · filed 2023-05-15 | $970.29K derived: sum of 3 quarters · filed 2023-05-15 | $591.96K derived: sum of 4 quarters · filed 2023-05-15 | ||||||
| 2021-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.08M derived: sum of 2 quarters · filed 2023-03-30 | $702.18K derived: sum of 3 quarters · filed 2023-03-30 | $1.71M 10-K · filed 2023-03-30 | ||||||
| 2021-09-30 | -$331.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$709.94K derived: sum of 2 quarters · filed 2022-11-14 | $302.12K 10-Q · filed 2022-11-14 | $302.12K derived: sum of 4 quarters · filed 2022-11-14 | ||||||
| 2021-06-30 | -$378.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $633.74K 10-Q · filed 2022-08-15 | $633.74K derived: sum of 3 quarters · filed 2022-08-15 | |||||||
| 2021-03-31 | $1.01M 10-Q · filed 2022-05-16 | $1.01M derived: sum of 2 quarters · filed 2022-05-16 | ||||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $0.00 10-K · filed 2022-03-15 | ||||||||
| 2020-11-30 | -$14.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-01-14 | -$61.97K 10-Q · filed 2021-01-14 | ||||||||
| 2020-09-30 | -$7.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | ||||||||
| 2020-08-31 | -$19.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-10-14 | -$47.02K 10-Q · filed 2020-10-14 | ||||||||
| 2020-06-30 | -$17.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $7.02K 10-Q · filed 2021-08-16 | ||||||||
| 2020-05-31 | -$27.88K 10-Q · filed 2020-07-07 | |||||||||
| 2020-03-31 | $25.00K 10-Q · filed 2021-05-17 | |||||||||
| 2020-02-29 | $53.93K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-04 | $31.01K derived: sum of 2 quarters · filed 2021-01-14 | $5.59K derived: sum of 3 quarters · filed 2021-01-14 | -$21.55K 10-K · filed 2020-05-04 | ||||||
| 2019-11-30 | -$22.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-01-14 | -$48.34K derived: sum of 2 quarters · filed 2021-01-14 | -$75.47K 10-Q · filed 2021-01-14 | |||||||
| 2019-08-31 | -$25.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-10-14 | -$52.56K 10-Q · filed 2020-10-14 | ||||||||
| 2019-05-31 | -$27.14K 10-Q · filed 2020-07-07 | |||||||||
| 2019-02-28 | $91.13K 10-K · filed 2020-05-04 | |||||||||
| 2018-11-30 | $60.55K 10-Q · filed 2020-01-10 | |||||||||
| 2018-08-31 | $78.20K 10-Q · filed 2019-10-08 | |||||||||
| 2018-05-31 | $0.00 10-Q · filed 2019-07-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |